Herein, we demonstrated that the expression of KIF14 was upregulated in sorafenib-resistant HCC cells, and its silencing inhibited the activation of AKT by downregulating p-AKT, but not AKT, to reverse the acquired resistance to sorafenib. This evidence concerns the gene KIF14 and hepatocellular carcinoma.